unaids/who working group on global hiv/aids/sti surveillance making hiv prevalence and aids...
TRANSCRIPT
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Making HIV Prevalence and AIDS Estimates
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
HIV/AIDS: Data Needs
What are the levels and trends in HIV infection?
Who is getting infected? Who is more at risk for or vulnerable to HIV
infection? Impact assessment (need for care, planning) Is the response effective?
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Courtesy of Thomas Rehle, Family Health International
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
UNAIDS/WHO Classification of epidemic states
LOW LEVEL: HIV prevalence has not consistently exceeded five percent
in any defined sub-population
CONCENTRATED HIV prevalence consistently over five percent in at least one
defined sub-population but below one percent in pregnant women in urban areas.
GENERALISED HIV prevalence consistently over one percent in pregnant
women nation-wide
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Three Steps in Making Estimates
Calculating HIV Prevalence
Curve Fitting
Generating other variables (e.g.,
mortality, incidence)
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Calculating HIV prevalence:Industrialized Countries
AIDS Back-calculation• Statistical method that allows estimating
the past HIV incidence required to provide the present level of AIDS cases, corrected by underreporting
• Curve fitting of past incidence
HIV Incidence estimates• HIV case reporting• Incidence studies using “detuned” ELISA
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Two different sets of procedures for:
low-level and concentrated epidemics• HIV is concentrated mainly in sub-populations
which may vary from country to country (e.g., IV drug users, CSW, MSM)
generalized epidemics• HIV has spread widely in the adult population• primary mode of transmission is heterosexual
Calculating HIV prevalence:Developing Countries
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Calculating HIV prevalence: Concentrated Epidemics
Estimates are made by adding together: the number of individuals assumed to
be infected in each identifiable sub-population at risk.
a minimum estimate of HIV infection in the general population
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Identify risk groupsEstimate size of groupsEstimate HIV prevalence in risk
groupsEstimate HIV prevalence in the
general populationSum of all groups
Calculating HIV prevalence:concentrated and low-level epidemics
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Estimating Prevalence in a Concentrated Epidemic
Group
Population -
Low estimate
Population -
High estimate
Population
prevalence,
low estimate
Population
prevalence,
high estimate
People
infected,
low-low
People infected,
low-high
People infected,
high-low
People infected,
high-high
Average, adults
with HIV
MSM 21,362 42,724 0.1 0.2 2,136 4,272 4,272 8,545 4,806 General population 2,093,489 2,050,764 0.001 0.003 2,093 6,280 2,051 6,152 4,144 CSW - - - STI attenders 21,362 42,724 0.033 0.053 705 1,132 1,410 2,264 1,378
2,136,213 2,136,213 0.13 0.26 4,935 11,685 7,733 16,962 10,329
Assumptions:
MSM population: Used 2% of adult men for low and 4% for highMSM Prevalence Rate Used 1995 prevalence data (15%), with 10% for low and 20% for high STI Population Used 1% of adult as low, 2% as high. Assume higher rates among menSTI Prevalence Rate 96-97 sentinel surveillance = 4.3%, used 3.3 as low and 5.3 as high General Population: Used 2000 UN population numbers for 15-49 minus the risk groupsGeneral population prevalence Based on anc sentinel data (0.55%). Used adjustment for rural, then had 0.1% for low, and 0.3% for high
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Estimating Prevalence in a Concentrated Epidemic
Population
Population Size
High
Population Size
Low
Percent Infected
High
Percent Infected
Low
Low-Low
Estimate
Low-High
Estimate
High-Low
Estimate
High-High
Estimate
IVDU 700,000 244,400 0.6 0.078 19,063 146,640 54,600 420,000
CSW Promiscuous People 502,260 125,565 0.01 0.003 377 377 377 5,023
People with STI 565,043 376,695 0.0084 0.0028 1,055 1,055 1,055 4,746
General (15-49) 23,345,698 24,366,340 0.0012 0.0007 17,056 17,056 17,056 28,015
Total 25,113,000 25,113,000 37,551 165,128 73,088 457,784
Assumptions:
IVDU Population Size Used high estimate from Karl's paper (and close to 6% of males) and 2% of males as low (see table below)IVDU Prevalence Rate Used High from Lev's study in Odessa, and a low from Karl's registered IVDU'sCSW * P.P. Population Used 2% of population for CSW/Promiscuous and .5% for low estimateCSW Prevalence Rate Used CSW prevalence rate from Karl's paper as high, half of that (overlap with IVDU) as lowSTI Population Used 15 times reported syphilis rate as high, and 10 times reported rate as lowSTI Prevalence Rate Used 50% higher than reported (Karl's paper) as high prevalence, 50% lower, as low General Population: Used 98 UN population numbers for 15-49 minus the risk groupsGeneral population prevalenceUsed anc rates for high and blood donors for low estimate
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Calculating HIV prevalence: Generalized Epidemics
Prevalence estimates are based primarily on surveillance data collected from women attending antenatal clinics.
Two groups of clinics based on their location• major urban areas• outside major urban areas
median prevalence rates are calculated separately for the two groups
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Calculating Prevalence
1.Determine median of urban and outside major urban sites
2. Adjust medians based on representativeness of sites
3. Apply adjusted rates to female urban and outside urban populations (15-49)
4.Use M/F ratio to determine number of men infected
5. Combine males and females to get adult rate
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Critical Issues in Estimating Prevalence
Representativeness of ANC sitesEffects of HIV infection on fertilityMale-to-female ratioUrban to rural prevalence
differential
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Representativeness of ANC:Other Factors
Age-related fertility reduction in HIV positive women
Changes in risk behaviors (condom use, contraception)
“Active aging” (risk beyond reproductive ages)
Selection and participation bias (users fees, availability/access to ANC services)
These factors have been identified for further study but are not considered in the present methodology
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Representativeness of ANC for total Population: Male/Female Differentials
0
10
20
30
40
50
60
15-19 20-24 25-29 30-39 40-49
% H
IV se
ro-p
ositi
ve
Men
Women
Population-based HIV prevalence in men and women - Lusaka, Zambia, 1995
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Assessing Urban/Rural Differentials: Surveillance Data for Kenya
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Comparison of HIV Prevalence Among Pregnant Women and All Adults 15-49
0
5
10
15
20
25
30
35
Lusaka Mposhi Mwanza Rakai-90 Rakai-91 Rakai-92 Kisumu
ANCPop
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Three Steps in Making Estimates
Calculating HIV Prevalence
Curve Fitting
Generating other variables (e.g.,
mortality, incidence)
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Curve Fitting
Epimodel was used to fit a curve to yearly estimates of adult prevalence. Not designed to make HIV projections. Not designed to fit prevalence curves Limited to the gamma curve May not suitable for slowly progressing
epidemics (Asia) New curve-fitting software is being
developed
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
EPIModel
Developed by WHO/GPA Tool for making short-term projections
of AIDS cases, AIDS mortality, paediatric AIDS and AIDS orphans.
NOT DESIGNED to make estimates or projections of prevalence of HIV infections
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Curve Fitting
Point prevalence estimates (at least one, the more the better!)
Year of initial spreadAssumptions about peak of the
epidemicPost-peak curve assumptions
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
0.0
10.0
20.0
30.0
40.0
50.0
1985 1987.5 1990 1992.5 1995 1997.5 2000
Year
URBAN OUTSIDE MED-URBAN
MED-OUTSIDE UNAIDS/WHO adult prevalence curve
HIV Prevalence for Pregnant WomenMajor Urban and Outside Major Urban Areas
Zambia
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Three Steps in Making Estimates
Calculating HIV Prevalence
Curve Fitting
Generating other variables (e.g.,
mortality, incidence, orphans)
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Generating Other Variables
Epimodel (or the new model) is used to generate additional information on
Incidence Vertical transmission Mortality (adult and child) Orphans
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Generating Other Variables:information needed
Population size (15-49) Progression rates from infection to
death Age specific fertility rates Fertility reduction for HIV Male-to-female ratio Mother-to-child transmission rate
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Age-specific information about population and fertility
United Nations Population Division estimates: age-specific fertility rates population figures
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Generating Other Variables Progression Rates
Infection to death for adults Median 9 years in countries with poor health care Median 11 years in countries with better health care
Infection to death for children Median 2 years in countries with poor health care Median 4 years in countries with better health care
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Progression Rates
Child Survival Rates
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Years since infection
Per
cen
t su
rviv
ing
SlowFast
Adult Survival Rates
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Years since infection
Per
cen
t su
rviv
ing
FastSlow
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Estimating Vertical Transmission
Male to female ratioFertility rateFertility reduction for HIV+Vertical transmission rate
(25% 10%) Impact of ARV prophylaxis on MTCT
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Mortality estimates
Due to the limitations in vital registration and case reporting, AIDS deaths are derived from the estimated HIV prevalence curve and the progression rate from infection to AIDS and death
Pre-AIDS mortality (deaths in HIV infected adults and children due to other causes unrelated to HIV) is deducted from the total mortality estimate
UN
AID
S/W
HO
W
ork
ing
Gro
up
on
Glo
bal
HIV
/AID
S/S
TI
Su
rvei
llan
ce
Projections
He who predicts the future lies, even if he is telling the truth!
Predictions are very difficult, particularly when the future is concerned.